Cano Health, Inc.
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Mark Kent
- Full Time Employees
- 4,010
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Address
- 9725 NW 117th Avenue Miami FL United States of America 33178
- IPO Date
- Jul 2, 2020
- CIK
- 0001800682
- Website
- canohealth.com
- Similar Companies
- Business
- Cano Health, Inc. operates as a value-based primary care provider specializing in comprehensive healthcare services with a focus on Medicare Advantage and senior populations. The company offers a wide range of products and services including primary care, specialty care, diagnostics, pharmacy services, wellness programs, and preventive care, primarily delivered through an integrated care model designed to improve patient outcomes and reduce healthcare costs. Its core operations emphasize the management of chronic diseases, population health management supported by data analytics and technology platforms such as CanoPanorama, and ensuring a seamless patient experience through coordinated care. Cano Health operates predominantly within the state of Florida after strategically exiting underperforming markets including California, New Mexico, Illinois, Texas, Nevada, and Puerto Rico between 2023 and early 2024. Founded in 2009 and headquartered in Miami, Florida, the company manages a network of approximately 143 medical centers across key geographies, focusing on dialysis, specialty, and primary care services tailored to seniors and Medicare beneficiaries. In the last two years, Cano Health underwent significant transformations including a Chapter 11 bankruptcy filing and reorganization, emerging as a private company in June 2024 with an improved capital structure and a $200 million capital infusion. The company has since prioritized operational efficiency and cost reductions, targeting $290 million in savings by year-end 2024 through workforce optimization, payer negotiations, and footprint consolidations. Management shifted strategic focus to the core Florida Medicare Advantage market alongside efforts to divest non-core business lines such as its ACO Reach operations and Medicaid lines with ongoing sale explorations. Leadership changes include the appointment of Eric Jenkins as CEO in April 2025, marking a renewed emphasis on operational excellence, growth, and patient-centered care innovation. Cano Health continues to leverage its integrated care model and technology-driven population health management to enhance accessibility and quality of healthcare services for its predominantly senior customer base while exploring prudent future expansions contingent on financial performance. The company is committed to advancing value-based care by combining medical, specialty, and pharmacy services under one roof to improve health outcomes and customer satisfaction in the competitive healthcare market it serves.
Cano Health Announces Agreement with Unsecured Creditors Committee and Court Approval of Disclosure Statement for its Reorganization Plan
NYSE Suspends Trading in Cano Health, Inc. (CANO) and Commences Delisting Proceedings
NYSE to Commence Delisting Proceedings Against Cano Health, Inc. (CANO)
Why Is Cano Health (CANO) Stock Down 51% Today?
Cano Health files for bankruptcy, receives $150-mln financing commitment
Cano Health Enters Restructuring Support Agreement with a Significant Majority of its Lenders to Strengthen Financial Position
Cano Health Receives NYSE Notice of Non-Compliance with Market Capitalization Criteria
Cano Health Announces Appointment of Two New Independent Directors
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Cano Health, Inc. - CANO
Cano Health's cash flow challenges spark analyst ‘sell' rating
NYSE to Commence Delisting Proceedings with Respect to the Warrants of Cano Health, Inc. (CANO/WS)
Cano Health stock price analysis: Bankruptcy risks are elevated
Cano Health, Inc. (CANO) Q3 2023 Earnings Call Transcript
Cano Health Provides Update on Third Quarter 2023 10-Q Filing
3 Stocks to Sell for a Clean Slate Heading Into 2024
CANO Stock Alert: Cano Health Undergoes 1-for-100 Reverse Stock Split
Cano Health Announces Consummation of Previously-Announced 1-for-100 Reverse Stock Split
Cano Health Announces Date to Report Third Quarter 2023 Results
Brace for Impact: 7 Stocks to Sell Amid Rising Troubles
Cano Health Files Preliminary Proxy Statement with the SEC to initiate plan for Reverse Stock Split